Micardis (telmisartan) — For Healthcare Professionals
Description: Learn more about out how Micardis® (telmisartan) and Micardis® HCT (telmisartan and hydrochlorothiazide) tablets can help lower your patients' blood pressure. Side effects may occur. MICARDIS is a once-daily prescription that is indicated for the treatment of hypertension (high blood pressure). MICARDIS 80 mg is indicated for cardiovascular risk reduction in patients unable to take ACE inhibitors. MICARDIS is not for pregnant women. MICARDIS HCT is not for cardiovascular risk reduction. MICARDIS HCT is not indicated for initial therapy. Please see Important Safety Information, including Boxed WARNING.
Keywords: micardis, micardis hct, blood pressure medication, blood pressure treatment, bp goal, blood pressure goal, blood pressure reduction, hypertension, hypertensive patients, arb, non-peptide angiotensin II receptor antagonist, micardis patient adherence program, micardis educational campaign, patient compliance micardis, patient adherence micardis, patient compliance hypertension, patient adherence hypertension, patient compliance antihypertensive therapy, patient adherence antihypertensive therapy, micardis patient web site, micardis special offers, micardis patient assistance, antihypertensive therapy patient assistance, micardis patient education, antihypertensive therapy patient education, micardis for healthcare professionals, micardis new indication, cardiovascular risk reduction, reduce cardiovascular risk, reducing cardiovascular risk, ace-intolerant, intolerance to ace inhibitors, patients unable to take ace inhibitors, twynsta
Tags: bpprotection, micardis, telmisartan, healthcare, professionals, tablets, micardis®, risk, hct, hypertension, patient, cardiovascular, patients, hydrochlorothiazide, calculator, dosing, tool, reduction, site, ace, reimbursement, blood, adherence, click, arbitrations, calculate, indicated, pressure, events, therapy, information, safety, used, treatment, twynsta, use, important, learn, inhibitors, web,
Bpprotection.com
|
Content Revalency:
Title: 40.00%
Description: 54.24%
Keywords: 62.00% | Document size: 27,135 bytes
More info: Whois - Trace Route - RBL Check |
|
| BPPROTECTION.COM - Site Location | |
| Country/Flag | |
| City/Region/Zip Code | Ridgefield, Connecticut, 06877 |
| Organization | Boehringer Ingelheim Pharmaceuticals |
| Internet Service Provider | Boehringer Ingelheim Pharmaceuticals |
| BPPROTECTION.COM - Domain Information | |
| Domain | BPPROTECTION.COM [ Traceroute RBL/DNSBL lookup ] |
| Registrar | COREHUB, S.R.L. CORE-111 (Nameshield) |
| Registrar URL | http://corehub.net |
| Whois server | whois.corehub.net |
| Created | 21-Feb-2008 |
| Updated | 20-Feb-2017 |
| Expires | 21-Feb-2019 |
| Time Left | 487 days 9 hours 48 minutes |
| Status | clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited clientTransferProhibited https://icann.org/epp#clientTransferProhibited clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited clientDeleteProhibited https://www.icann.org/epp#clientDeleteProhibited clientTransferProhibited https://www.icann.org/epp#clientTransferProhibited clientUpdateProhibited https://www.icann.org/epp#clientUpdateProhibited |
| DNS servers | NS2.OBSERVATOIREDESMARQUES.FR 80.74.69.8 NS3.NAMESHIELD.NET 195.246.156.74 OBS.NS1.FR 81.92.84.146 ns2.observatoiredesmarques.fr 80.74.69.8 obs.ns1.fr 81.92.84.146 ns3.nameshield.net 45.63.17.113 ns3.nameshield.net 45.63.17.113 |
| BPPROTECTION.COM - DNS Information | |
| IP Address | 148.188.147.140 ~ Whois - Trace Route - RBL Check 148.188.155.140 ~ Whois - Trace Route - RBL Check |
| Domain Name Servers | pdns2.cscdns.net 69.36.145.33 pdns1.cscdns.net 209.112.114.33 |
| Mail Exchange | mail1.boehringer-ingelheim.com 148.188.1.170 mail2.boehringer-ingelheim.com 148.188.1.172 mail3.boehringer-ingelheim.com 148.188.192.91 mail4.boehringer-ingelheim.com 148.188.192.93 |
| Site Response Header | |
| Response | HTTP/1.1 301 Moved permanently |
| Server | Apache/2.2.3 (Red Hat) |
| Date | Sat, 09 Apr 2011 11:19:07 GMT |
| Content-Type | text/html; charset=UTF-8 |
| Cookie | WEBTRENDS_BI=j2DWNgQL8ZYYzBjKbDLlQ6QFpCjZsnFkWmWV5vwh32hxCGRFnfqY!-1746952!1302347947765; expires=Friday, 13-Apr-2040 08:06:46 GMT; path=/ |